COMMUNIQUÉS West-GlobeNewswire

Nextech Named Tampa Bay “Technology Company of the Year” for 2017 at the 14th Annual Tampa Bay Tech Awards

11/11/2017 - 23:28

TAMPA, Fla., Nov. 11, 2017 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of health care technology solutions for specialty physician practices, has been named the Technology Company of the Year for 2017 by [...]

Argos Therapeutics Provides Update on Immunology Data from the Phase 3 ADAPT Trial Presented at the SITC 2017 Annual Meeting

11/11/2017 - 14:30

DURHAM, N.C., Nov. 11, 2017 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (NASDAQ: ARGS ), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the [...]

Punjab province in Pakistan signs agreement with Novartis Access against chronic diseases

11/11/2017 - 14:01

Poor patients in Punjab will have access to high-quality medicines against noncommunicable, chronic diseases thanks to agreement between government and Novartis Access Punjab government will make medicines available [...]

CRISPR Therapeutics Highlights New Additions to Portfolio of Allogeneic CRISPR-based CAR-T Therapies at SITC Annual Meeting

11/11/2017 - 02:00

- CRISPR-based CAR-T cell therapy candidates targeting CD19+, BCMA and CD70 demonstrate high editing rates, and potent anti-tumor activity in preclinical models - - Expanding applicability of CRISPR-based CAR-T therapy [...]

TOMI Environmental Solutions, Inc. to Hold Third Quarter 2017 Financial Results Conference Call on November 16, 2017

11/11/2017 - 00:40

BEVERLY HILLS, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global decontamination and infection prevention company that specializes in disinfection/ [...]

Restoration Robotics, Inc. to Participate in Two International Medical Meetings Focused on the Asia-Pacific Market

11/11/2017 - 00:24

SAN JOSE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Restoration Robotics, Inc. (NASDAQ: HAIR ) announced today that the Company will participate in two international medical meetings focused on the Asia-Pacific market [...]

Novartis brolucizumab (RTH258) demonstrates superiority versus aflibercept in key secondary endpoint measures of disease activity in nAMD, a leading cause of blindness

10/11/2017 - 23:52

Brolucizumab, the first and only anti-VEGF to maintain a majority of patients on a 12-week treatment schedule immediately following loading phase in Phase III trials, met primary endpoint of non-inferiority vs [...]

Three-year Follow-up Phase 3 Data Provide Additional Information on Efficacy, Durability and Safety of Investigational LUXTURNA™ (voretigene neparvovec) in Patients with Biallelic RPE65-mediated Inherited Retinal Disease

10/11/2017 - 23:05

PHILADELPHIA, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE ), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced new three-year [...]

Skyline Medical to Hold Business Update Conference Call on November 15, 2017

10/11/2017 - 23:00

MINNEAPOLIS, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]

CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation

10/11/2017 - 22:15

IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ: CBMX ) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based reproductive health and [...]

ZIOPHARM to Present at the Stifel 2017 Healthcare Conference

10/11/2017 - 22:05

BOSTON, Nov. 10, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP ) today announced that David Mauney, M.D., CBO and interim COO, will present at the Stifel 2017 Healthcare Conference in New York on [...]

Voyager Therapeutics Announces Closing of Public Offering of Common Stock

10/11/2017 - 22:05

CAMBRIDGE, Mass., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, [...]

MediWound to Host Third Quarter 2017 Financial Results Conference Call on November 16, 2017 at 8:30 a.m. Eastern Time

10/11/2017 - 22:01

YAVNE, Israel, Nov. 10, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD ), a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn and wound [...]

Five Prime Therapeutics Presents Poster on FGFR2b Expression and Immune Signature in Urothelial Cancer at the Society for Immunotherapy of Cancer 32nd Annual Meeting

10/11/2017 - 18:30

SOUTH SAN FRANCISCO, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc . (Nasdaq: FPRX ), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology [...]

Dr. Ramzan Zakir Elected to the American Health Council’s Board of Physicians

10/11/2017 - 17:19

NEW YORK, Nov. 10, 2017 (GLOBE NEWSWIRE) -- The American Health Council is proud to elect Dr. Ramzan Zakir, current Clinical Assistant Professor of Medicine at Heart and Vascular Institute of Central New Jersey, to [...]

Symposium and Panel Discussion on Nymox's Fexapotide To Be Held at American Urological Association North Central Section Annual Meeting in Scottsdale AZ November 15

10/11/2017 - 16:30

HASBROUCK HEIGHTS, N.J., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX ) is pleased to report that a Symposium on Fexapotide Triflutate studies will be held at the Annual Meeting of [...]

Inovio Pharmaceuticals Presents Immuno-Oncology Advancements At Society for Immunotherapy of Cancer Conference

10/11/2017 - 16:27

PLYMOUTH MEETING, Pa., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced that two of its cancer immunotherapies demonstrated antigen-specific T-cell stimulation in phase 1 [...]

Progressive Care Announces Third Quarter Conference Call and Webcast with Investors on November 14, 2017

10/11/2017 - 16:21

MIAMI, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of [...]

eFFECTOR Therapeutics Presents Preclinical Data for eFT508 that Demonstrates Beneficial Immunological Effects

10/11/2017 - 16:00

SAN DIEGO, Nov. 10, 2017 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced a poster presentation of [...]